Robert Reiter, MD, MBA
SPORE Principal Investigator
Developing an N-Terminal Inhibitor of the Androgen Receptor
Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
A Targetable Master Regulator of Lethal Prostate Cancer